Skip to content

Assessment of Vital Pulp Therapy in Permanent Molars

Clinical Evaluation of Vital Pulp Therapy in Young Permanent Molars With Irreversible Pulpitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03410134
Enrollment
300
Registered
2018-01-25
Start date
2017-11-01
Completion date
2023-08-01
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries Extending to Pulp, Pulp Disease, Dental

Keywords

Permanent teeth, Vital pulp therapy, MTA

Brief summary

The purpose of this study is to evaluate the long term clinical performance of vital pulp therapy of young permanent teeth with irreversible pulpitis

Detailed description

Permanent molar teeth meeting the inclusion criteria will be included into the study. Following local anaesthesia and dental dam application, caries excavation will be performed; and after exposure, the pulp will be amputated to the level of the canal orifices (full pulpotomy) using a sterile high-speed round bur under water coolant. After haemostasis is achieved, Mineral trioxide aggregate (MTA) will be gently placed over the pulp to a thickness of 2-3 mm and the tooth will be restored using glass ionomer cement and composite resin. A postoperative periapical radiograph will be taken. Patients will be reviewed at 6., 12., 24. and 36. months for clinical and radiographical success. The data will be analysed statistically using chi square test.

Interventions

DEVICENeoMTA

NeoMTA™ Plus® root and pulp treatment material is a powder/gel system with no resin. The components are an extremely fine powder primarily tricalcium and dicalcium silicate plus a water-based gel.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients and parents of the patients who accept to participate and sign the informed consent * Patients who have at least one vital permanent molar teeth with irreversible pulpitis symptoms * Teeth which can be restorable after the treatment. * Teeth which has good periodontal health and in the absence of sinus tracts or swelling.

Exclusion criteria

* Patients and parents of the patients who does not accept to participate and sign the informed consent * Teeth which have dentoalveolar or extraoral swelling * Teeth which have periodontal disease, mobility or alveolar bone loss * Teeth which are not restorable * Patients who are not cooperative with the treatment

Design outcomes

Primary

MeasureTime frameDescription
Clinical evaluation of vital pulp therapy in permanent teeth with irreversible pulpitis3 yearsLong-term success of vital pulp therapy in young permanent teeth with irreversible pulpitis. Evaluation criteria will be; 1. spontaneous pain (absent/present); 2. tenderness to percussion/palpation (absent/present); 3. mobility (no mobility/ 1mm/ 2mm/ 3mm mobility) 4. swelling (absent/present); 5. fistula (absent/present) 6. periapical/interradicular radiolucency (absent/present); 7. widened periodontal ligament (absent/present); 8. loss of lamina dura (absent/present); 9. internal/external root resorption (absent/present).

Countries

Turkey (Türkiye)

Contacts

Primary ContactZafer C Cehreli, Prof
zcehreli@gmail.com00905353197969
Backup ContactGizem E Unverdi
erbasgizem@yahoo.com00905052805736

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026